In OSCC, the opposing roles of NOTCH signaling in cancer were observed in which NOTCH receptor family members can be tumor-suppressors (NOTCH1, 2) or oncogene (NOTCH1, 3) [37,41,42]. This evidence concerns the gene NOTCH1 and neoplasm.